Alzamend Neuro ALZN
NASDAQ ALZN
$1.68 +0.00 (+0.00%)
As of: Sep 9, 2026 · 3:59 PM EDT

Alzamend Neuro (ALZN) Amortizatization of Intangibles (2021 - 2024)

Alzamend Neuro's (ALZN) quarterly Amortizatization of Intangibles came in at $9286.0 in Q3 2024, up 155.1% quarter-over-quarter from -$16853.0 in Q1 2022.

Analysis

Alzamend Neuro (ALZN) Amortizatization of Intangibles (2021 - 2024) Analysis & Trends

Alzamend Neuro has disclosed Amortizatization of Intangibles across 3 years of filings, most recently posting $9286.0 for Q3 2024.

  • In Q3 2024, Amortizatization of Intangibles changed N/A year-over-year to $9286.0; the TTM figure through Apr 2025 stood at $9286.0 (changed N/A YoY), while the FY2025 annual figure was $9286.0, up 1200.56% from the prior year.
  • Amortizatization of Intangibles came in at $9286.0 for Q3 2024 at Alzamend Neuro, up from -$16853.0 in the prior quarter.
  • In the past five years, Amortizatization of Intangibles ranged from a high of $51821.0 in Q1 2021 to a low of -$16853.0 in Q1 2022.
  • Average Amortizatization of Intangibles over 3 years is $16746.2, with a median of $17057.0 recorded in 2021.
  • The largest YoY upside for Amortizatization of Intangibles was 132.52% in 2022 against a maximum downside of 132.52% in 2022.
  • Over 3 years, Amortizatization of Intangibles stood at $24828.0 in 2021, then tumbled by 167.88% to -$16853.0 in 2022, then surged by 155.1% to $9286.0 in 2024.
  • Per Business Quant data, the three most recent Amortizatization of Intangibles figures were $9286.0 in Q3 2024, -$16853.0 in Q1 2022, and $24828.0 in Q4 2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Amortizatization of Intangibles (Qtr)
1 Amgen 236.37 Bn 222.38 Bn 7.24 Bn -
2 Gilead Sciences 187.38 Bn 184.12 Bn 6.22 Bn 600.00 Mn
3 Vertex Pharmaceuticals 138.36 Bn 130.51 Bn 2.84 Bn -
4 Regeneron Pharmaceuticals 85.09 Bn 77.10 Bn 3.93 Bn -
5 Argenx Se 63.93 Bn 58.75 Bn 1.37 Bn -
6 Moderna 58.07 Bn 52.94 Bn 52.00 Mn -
7 Alnylam Pharmaceuticals 35.59 Bn 32.28 Bn 992.69 Mn -
8 Biogen 32.63 Bn 31.34 Bn 1.96 Bn -
9 Insmed 27.57 Bn 26.41 Bn 358.27 Mn 678,000.00
10 Alzamend Neuro 5.54 Mn 5.54 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jul 31, 2024 9,286.00
Jan 31, 2022 -16,853.00
Oct 31, 2021 24,828.00
Jul 31, 2021 4,795.00
Apr 30, 2021 26,600.00
Jan 31, 2021 51,821.00